Advertisement

---

ISIS PHARMACEUTICALS INC.

Isis Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference

[2013-07-02] -


Breaux Castleman Joins Isis Pharmaceuticals' Board of Directors

[2013-06-25] -


Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions in Triglycerides and APOC-III in Patients with High Triglycerides and Type 2 Diabetes

[2013-06-23] - Improvements in glucose control and insulin sensitivity also observed
Conference call webcast and slide presentation Monday, June 24, 8:30 a.m. ET at www.isispharm.com


Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House

[2013-06-18] -


Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies

[2013-06-10] -


Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca

[2013-06-06] -


Isis Pharmaceuticals to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

[2013-06-05] -


Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZeneca for ISIS-AR Rx to Treat Prostate Cancer

[2013-06-03] - Successful collaboration with AstraZeneca developing two novel cancer antisense drugs
Isis to conduct conference call webcast today, June 3, at 2:00 p.m. ET, to discuss recent highlights from its cancer franchise


Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer

[2013-06-03] - Data presented today at the American Society of Clinical Oncology


Isis Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares

[2013-05-31] -


Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

[2013-05-23] -


Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference

[2013-05-13] -


Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

[2013-05-09] -


Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec

[2013-05-09] -


Isis Pharmaceuticals Prices Public Offering Of Common Stock

[2013-05-08] -


Isis Reports Financial Results and Highlights for First Quarter 2013

[2013-05-07] - - Conference Call Webcast Tuesday, May 7, 4:30 p.m. ET at www.isispharm.com


Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock

[2013-05-07] -


1 - 2
Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers